SAB Biotherapeutics, Inc. (SABS)
Recent Filing Index
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover | ||
| Statements | ||
| Condensed Balance Sheets | — |
|
| Consolidated Balance Sheets | ||
| Condensed Balance Sheets (P) | — |
|
| Consolidated Balance Sheets (P) | ||
| Condensed Consolidated Statements of Operations (unaudited) | — |
|
| Condensed Statements of Operations (unaudited) | — |
|
| Consolidated Statements of Operations and Comprehensive Income (loss) | ||
| Consolidated Statements of Operations and Comprehensive Loss | ||
| Condensed Consolidated Statements of Operations (unaudited) (P) | — |
|
| Condensed Statements of Changes In Stockholders' Equity (unaudited) | — |
|
| Consolidated Statements of Changes In Stockholders' Equity | ||
| Consolidated Statements of Operations and Comprehensive Loss (P) | ||
| Consolidated Statements of Cash Flows | ||
| Consolidated Statements of Changes In Stockholders' Equity (P) | ||
| Condensed Statements of Cash Flows (unaudited) | — |
|
| Notes | ||
| Accrued Expenses and Other Current Liabilities | ||
| Award Timing Disclosure | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy, and Governance | — |
|
| Earnings Per Share | ||
| Employee Benefit Plan | ||
| Fair Value Measurements | ||
| Income Taxes | ||
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Investment Securities | — |
|
| Investments | ||
| Leases | ||
| Nature of Business | ||
| New Accounting Standards | ||
| Notes Payable | ||
| Pay Vs Performance Disclosure | ||
| Property, Plant and Equipment | ||
| Related Party Transactions | ||
| Revenue | ||
| Segment Reporting | ||
| Stock Option Plans | ||
| Stock-based Compensation | — |
|
| Stockholders' Equity | ||
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Warrants | ||